Kim, J.H.; Kim, S.I.; Kim, E.T.; Ha, H.I.; Lee, D.-e.; Lee, Y.J.; Lee, J.-Y.; Kim, S.; Kim, S.W.; Kim, Y.T.;
et al. The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer. Cancers 2025, 17, 756.
https://doi.org/10.3390/cancers17050756
AMA Style
Kim JH, Kim SI, Kim ET, Ha HI, Lee D-e, Lee YJ, Lee J-Y, Kim S, Kim SW, Kim YT,
et al. The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer. Cancers. 2025; 17(5):756.
https://doi.org/10.3390/cancers17050756
Chicago/Turabian Style
Kim, Ji Hyun, Se Ik Kim, Eun Taeg Kim, Hyeong In Ha, Dong-eun Lee, Yong Jae Lee, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Young Tae Kim,
and et al. 2025. "The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer" Cancers 17, no. 5: 756.
https://doi.org/10.3390/cancers17050756
APA Style
Kim, J. H., Kim, S. I., Kim, E. T., Ha, H. I., Lee, D.-e., Lee, Y. J., Lee, J.-Y., Kim, S., Kim, S. W., Kim, Y. T., Park, S.-Y., Lim, M. C., & Nam, E.-J.
(2025). The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer. Cancers, 17(5), 756.
https://doi.org/10.3390/cancers17050756
